Medication leaflets

Leaflet NEORECORMON 10000UI / 0.6ml solution for injection in pre-filled syringe

Product code:
W64395002
Quantity:
6
Indicated for:
anemia
Route of administration:
injectable
Substance:
epoetin beta (erythropoiesis-stimulating agent)
ATC
B03XA01 — Blood and blood forming organs | Other antianemic preparations
Epoetin beta is a medication used to treat anemia, especially in patients with chronic kidney failure or those undergoing dialysis. This medicine stimulates the production of red blood cells, helping to increase hemoglobin levels and reduce symptoms of fatigue. Epoetin beta is usually administered by subcutaneous or intravenous injection, as directed by the doctor.

Treatment with epoetin beta is closely monitored by the medical team, as the dose must be adjusted based on the body's response and hemoglobin levels. It is important for patients to strictly follow the doctor's recommendations and have regular blood tests to prevent complications.

Side effects may include high blood pressure, headaches, joint pain, or reactions at the injection site. In rare cases, severe allergic reactions or an increased risk of blood clots may occur.

Epoetin beta is an essential treatment for patients with severe anemia, but it requires constant medical supervision to ensure the therapy's effectiveness and safety. Open communication with the doctor is crucial for proper management of the treatment.

Official documents

EMA leaflet
Added to database:
04/11/2008
Source record updated:
02/05/2025

General data about NEORECORMON 10000UI / 0.6ml

Substance:
epoetin beta
Date of latest medicines list:
01-06-2026
Product code:
W64395002
Concentration:
10000UI / 0.6ml
Pharmaceutical form:
solution for injection in pre-filled syringe
Packing volume:
0,6ml
Product type:
Original
Price:
1913.07 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ROCHE PHARMA AG - GERMANIA
Holder:
ROCHE REGISTRATION GMBH - GERMANIA
Number:
31/1998/36
Shelf life:
2 years

Pharmaceutical forms available for epoetin beta

Concentrations available for epoetin beta

  • 10000UI/0.6ml
  • 10000UI/ml
  • 1000UI/0.3ml
  • 1000UI/ml
  • 20000UI/0.6ml
  • 20000UI/ml
  • 2000UI/0.3ml
  • 30000UI/0.6ml
  • 3000I/0.3ml
  • 4000UI/0.3ml
  • 50000UI/ml
  • 5000UI/0.3ml
  • 500UI/0.3ml
  • 60000UI/ml
  • 6000UI/0.3ml

Other substances similar to epoetin beta

Compensation lists for NEORECORMON 10000UI / 0.6ml Egis

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price
1913.07 RON
Copayment
1913.07 RON
Patient
0.00 RON

G25 (C1) - Chronic renal failure

Price
1913.07 RON
Copayment
1913.07 RON
Patient
0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
1913.07 RON
Copayment
1913.07 RON
Patient
0.00 RON

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure

Price
1913.07 RON
Copayment
1913.07 RON
Patient
0.00 RON